Todd W. Rockway

1.3k citations

38 papers · 940 indexed · h-index 20

Hepatology top 5%
- Hepatitis C virus research 6
Cancer Research top 10%
- Protease and Inhibitor Mechanisms 9
Organic Chemistry top 10%
Hematology top 10%
Infectious Diseases top 10%
- HIV/AIDS drug development and treatment 8
Oncology
- Peptidase Inhibition and Analysis 8
Molecular Biology
- Chemical Synthesis and Analysis 5
- Receptor Mechanisms and Signaling 5
Social Psychology
- Neuroendocrine regulation and behavior 5
Cardiology and Cardiovascular Medicine
- Heart Failure Treatment and Management 4

Co-authors: Vincent L. Giranda V. Nienaber Stephen W. Fesik Robert T. Gampe Kent D. Stewart Moshe Weitzberg Victor J. Hruby Wood Yee Chan
Cited by: Hepatology Cancer Research Organic Chemistry
Journals: Biochemistry (4 papers)Biochemical and Biophysical Research Communications (1 paper)Journal of Medicinal Chemistry (3 papers)
Partner nations: United States United Kingdom Poland

In The Last Decade

Todd W. Rockway

37 papers receiving 877 citations

Peers

Countries citing papers authored by Todd W. Rockway

Since Specialization

Citations

This map shows the geographic impact of Todd W. Rockway's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Todd W. Rockway with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Todd W. Rockway more than expected).

Fields of papers citing papers by Todd W. Rockway

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Todd W. Rockway. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Todd W. Rockway. The network helps show where Todd W. Rockway may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Todd W. Rockway, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Todd W. Rockway Line = papers co-authored together Todd W. Rockway links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Discovery of fluorobenzimidazole HCV NS5A inhibitors Bioorganic & Medicinal Chemistry Letters ·John T. Randolph,Charles A. Flentge,Pamela Donner,Todd W. Rockway,Sachin Patel,Lissa T.J. Nelson,Douglas K. Hutchinson,Rubina Mondal,Neeta Mistry,Thomas Reisch,Tatyana Dekhtyar,Preethi Krishnan,Edward Tam,DeAnne Stolarik,David W. A. Beno,Rolf Wagner,Clarence J. Maring,Warren M. Kati	2016	4
2	Synthesis and SAR of novel 1,1-dialkyl-2(1H)-naphthalenones as potent HCV polymerase inhibitors Bioorganic & Medicinal Chemistry Letters ·Todd D. Bosse,Daniel P. Larson,Rolf Wagner,Doug K. Hutchinson,Todd W. Rockway,Warren M. Kati,Yaya Liu,Sherie Masse,Tim Middleton,Hongmei Mo,Debra Montgomery,Wen Jiang,Gennadiy Koev,Dale J. Kempf,Akhter Molla	2007	16
3	Inhibitors of HCV NS5B polymerase: Synthesis and structure–activity relationships of N-1-benzyl and N-1-[3-methylbutyl]-4-hydroxy-1,8-naphthyridon-3-yl benzothiadiazine analogs containing substituents on the aromatic ring Bioorganic & Medicinal Chemistry Letters ·Todd W. Rockway,Rong Zhang,Dachun Liu,David A. Betebenner,Keith F. McDaniel,John K. Pratt,David W. A. Beno,Debra Montgomery,Wen Jiang,Sherie Masse,Warren M. Kati,Tim Middleton,Akhteruzzaman Molla,Clarence J. Maring,Dale J. Kempf	2006	22
4	Inhibitors of HCV NS5B polymerase: Synthesis and structure–activity relationships of N-alkyl-4-hydroxyquinolon-3-yl-benzothiadiazine sulfamides Bioorganic & Medicinal Chemistry Letters ·A. Chris Krueger,Darold L. Madigan,Wen Jiang,Warren M. Kati,Dachun Liu,Yaya Liu,Clarence J. Maring,Sherie Masse,Keith F. McDaniel,Tim Middleton,Hongmei Mo,Akhteruzzaman Molla,Debra Montgomery,John K. Pratt,Todd W. Rockway,Rong Zhang,Dale J. Kempf	2006	24
5	Interaction with the S1β-pocket of urokinase: 8-heterocycle substituted and 6,8-disubstituted 2-naphthamidine urokinase inhibitors Bioorganic & Medicinal Chemistry Letters ·Michael Wendt,Andrew Geyer,William J. McClellan,Todd W. Rockway,Moshe Weitzberg,Xumiao Zhao,Robert A. Mantei,Kent D. Stewart,V. Nienaber,Vered Klinghofer,Vincent L. Giranda	2004	24
6	Naphthamidine urokinase plasminogen activator inhibitors with improved pharmacokinetic properties Bioorganic & Medicinal Chemistry Letters ·Milan Bruncko,William J. McClellan,Michael Wendt,Daryl R. Sauer,Andrew Geyer,Christopher R. Dalton,Michele A. Kaminski,Moshe Weitzberg,Jane Gong,Joseph F. Dellaria,Robert A. Mantei,Xumiao Zhao,V. Nienaber,Kent D. Stewart,Vered Klinghofer,Jennifer B. Bouska,Todd W. Rockway,Vincent L. Giranda	2004	19
7	Inhibition of human immunodeficiency virus type I integrase by naphthamidines and 2-aminobenzimidazoles Antiviral Research ·Timothy Middleton,H LIM,Debra Montgomery,Todd W. Rockway,Haolin Tang,Xueheng Cheng,Liangjun Lu,Hongmei Mo,W E Kohlbrenner,Abul Hossain Molla	2004	22
8	Pyridone-Containing farnesyltransferase inhibitors: synthesis and biological evaluation Bioorganic & Medicinal Chemistry Letters ·Lisa Hasvold,Weibo Wang,Stephen L. Gwaltney,Todd W. Rockway,Lissa T.J. Nelson,Robert A. Mantei,Stephen A. Fakhoury,Gerard M. Sullivan,Qun Li,Nan‐Horng Lin,Le Wang,Haiying Zhang,Jerome Cohen,Wen‐Zhen Gu,Kennan C. Marsh,Joy Bauch,Saul H. Rosenberg,Hing L. Sham	2003	64
9	Inhibitors of the Proteolytic Activity of Urokinase Type Plasminogen Activator Current Pharmaceutical Design ·Todd W. Rockway,Vincent L. Giranda	2003	34
10	Inhibitors of the Protease Domain of Urokinase-Type Plasminogen Activator Current Pharmaceutical Design ·Todd W. Rockway,V. Nienaber,Vincent L. Giranda	2002	49
11	Structure-directed discovery of potent non-peptidic inhibitors of human urokinase that access a novel binding subsite Structure ·V. Nienaber,Donald J. Davidson,Rohinton Edalji,Vincent L. Giranda,Vered Klinghofer,Jack Henkin,Peter Magdalinos,Robert A. Mantei,S.M. Merrick,Jean M. Severin,Richard A. Smith,Kent D. Stewart,Karl A. Walter,Jieyi Wang,Michael Wendt,Moshe Weitzberg,Xumiao Zhao,Todd W. Rockway	2000	46
12	An Efficient Process for the Synthesis of Renin Inhibitor, ABT-517 Synthetic Communications ·Pulla Reddy Singam,Curt W. Bradshaw,Jerome A. Menzia,B. A. Narayanan,Todd W. Rockway,Noel Welch,Jien-Heh J. Tien	1996	2
13	Truncated atrial natriuretic factor analogs retain full agonist activity Canadian Journal of Physiology and Pharmacology ·William H. Holleman,Gerald P. Budzik,Edward M. Devine,David M. Pollock,T. J. Opgenorth,Abigail Thomas,Thomas W von Geldern,Todd W. Rockway	1991	3
14	Effects of conformational constraint in 2- and 8-cycloleucine analogues of oxytocin and [1-penicillamine] oxytocin examined by circular dichroism and biosassay Journal of Protein Chemistry ·I. Frič,Jan Hlaváček,Todd W. Rockway,Wood Yee Chan,Victor J. Hruby	1990	7
15	Atrial natriuretic peptide antagonists: biological evaluation and structural correlations. Molecular Pharmacology ·Thomas W von Geldern,Gerald P. Budzik,Terry P. Dillon,William H. Holleman,Mikael Holst,Yasuo Kiso,Eugene I. Novosad,T. J. Opgenorth,Todd W. Rockway,Alexandra M. Thomas	1990	33
16	NMR study of the solution conformation of rat atrial natriuretic factor (7-23) in sodium dodecyl sulfate micelles Biochemistry ·Edward T. Olejniczak,Robert T. Gampe,Todd W. Rockway,Stephen W. Fesik	1988	24
17	Two‐Dimensional NMR studies of [Pro‐10] atrial natriuretic factor [7‐23] Biopolymers ·Robert T. Gampe,Peter J. Connolly,Todd W. Rockway,Stephen W. Fesik	1988	13
18	Application of isotope-filtered 2D NOE experiments in the conformational analysis of atrial natriuretic factor(7–23) Journal of Magnetic Resonance (1969) ·Stephen W. Fesik,Robert T. Gampe,Todd W. Rockway	1987	43
19	Divergence of ANF analogs in smooth muscle cell cGMP response and aorta vasorelaxation: Evidence for receptor subtypes Biochemical and Biophysical Research Communications ·Gerald P. Budzik,Susan Firestone,Eugene N. Bush,Peter J. Connolly,Todd W. Rockway,Virender K. Sarin,William H. Holleman	1987	43
20	Mo NMR spectra of Dioxomolybdenum(VI) complexes Inorganica Chimica Acta ·Kenner A. Christensen,Philip E. Miller,Martin Minelli,Todd W. Rockway,John H. Enemark	1981	23

About Todd W. Rockway

Todd W. Rockway is a scholar working on Hepatology, Cancer Research and Infectious Diseases, having authored 38 papers that have together received 940 indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (9 papers), Peptidase Inhibition and Analysis (8 papers), HIV/AIDS drug development and treatment (8 papers), Hepatitis C virus research (6 papers), Chemical Synthesis and Analysis (5 papers), Neuroendocrine regulation and behavior (5 papers), Receptor Mechanisms and Signaling (5 papers) and Heart Failure Treatment and Management (4 papers). The work is most often cited by research in Hepatology (162 citations), Cancer Research (182 citations) and Organic Chemistry (237 citations). Todd W. Rockway has collaborated with scholars based in United States, United Kingdom and Poland. Frequent co-authors include Vincent L. Giranda, V. Nienaber, Stephen W. Fesik, Robert T. Gampe, Kent D. Stewart, Moshe Weitzberg, Victor J. Hruby, Wood Yee Chan, Robert A. Mantei and Gerald P. Budzik. Their work appears in journals such as Biochemistry, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact